WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H413668
CAS#: 6153-33-9 (napadisylate)
Description: Mebhydrolin napadisylate is an antihistamine.
Hodoodo Cat#: H413668
Name: Mebhydrolin napadisylate
CAS#: 6153-33-9 (napadisylate)
Chemical Formula: C48H48N4O6S2
Exact Mass: 840.30
Molecular Weight: 841.054
Elemental Analysis: C, 68.55; H, 5.75; N, 6.66; O, 11.41; S, 7.62
Related CAS #: 6153-33-9 (napadisylate) 524-81-2 (free base)
Synonym: Mebhydrolin napadisylate; Incidal; Omeril; Mebhydroline 1,5-naphthalenedisulfonate salt
IUPAC/Chemical Name: 1,5-Naphthalenedisulfonic acid, compd. with 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido(4,3-b)indole (1:2)
InChi Key: CJUOSBUQOWKEKJ-UHFFFAOYSA-N
InChi Code: InChI=1S/2C19H20N2.C10H8O6S2/c2*1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15;11-17(12,13)9-5-1-3-7-8(9)4-2-6-10(7)18(14,15)16/h2*2-10H,11-14H2,1H3;1-6H,(H,11,12,13)(H,14,15,16)
SMILES Code: O=S(C1=C2C=CC=C(S(=O)(O)=O)C2=CC=C1)(O)=O.CN(C3)CCC(N4CC5=CC=CC=C5)=C3C6=C4C=CC=C6.CN(C7)CCC(N8CC9=CC=CC=C9)=C7C%10=C8C=CC=C%10
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 841.05 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: McEwen J, Strickland WJ. Mebhydrolin napadisylate. A possible cause of reversible agranulocytosis and neutropenia. Med J Aust. 1982 Nov 27;2(11):523-5. PMID: 6130466.
2: Edoute Y, Nagler A, Brenner B. [Agranulocytosis associated with mebhydrolin napadisylate (Incidal)]. Harefuah. 1984 Mar 1;106(5):208-9. Hebrew. PMID: 6724409.
3: Li Z, Ye CY, Zhao TY, Yang L. Model of genetic and environmental factors associated with type 2 diabetes mellitus in a Chinese Han population. BMC Public Health. 2020 Jun 29;20(1):1024. doi: 10.1186/s12889-020-09130-5. PMID: 32600448; PMCID: PMC7325035.
4: Stoop D, Vercammen L, Polyzos NP, de Vos M, Nekkebroeck J, Devroey P. Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. Fertil Steril. 2012 Jun;97(6):1328-30. doi: 10.1016/j.fertnstert.2012.03.012. Epub 2012 Mar 30. PMID: 22464081.
5: Bello AI, Quartey JN, Appiah LA. Screening for developmental delay among children attending a rural community welfare clinic in Ghana. BMC Pediatr. 2013 Aug 13;13:119. doi: 10.1186/1471-2431-13-119. PMID: 23937954; PMCID: PMC3751115.
6: Nakagawa H, Fujiwara N, Tateishi R, Arano T, Nakagomi R, Kondo M, Minami T, Sato M, Uchino K, Enooku K, Asaoka Y, Kondo Y, Shiina S, Yoshida H, Koike K. Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver- related, and liver-unrelated mortality in chronic hepatitis C patients. J Gastroenterol Hepatol. 2015 Feb;30(2):379-88. doi: 10.1111/jgh.12719. PMID: 25168107.
7: Lee YC, Lin CH, Lin MS, Lin JW, Chang CH, Lai MS. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study. J Clin Psychopharmacol. 2013 Dec;33(6):782-9. doi: 10.1097/JCP.0b013e31829c970e. PMID: 24091857.
8: Wu B, Wang HL, Cee VJ, Lanman BA, Nixey T, Pettus L, Reed AB, Wurz RP, Guerrero N, Sastri C, Winston J, Lipford JR, Lee MR, Mohr C, Andrews KL, Tasker AS. Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Bioorg Med Chem Lett. 2015 Feb 15;25(4):775-80. doi: 10.1016/j.bmcl.2014.12.091. Epub 2015 Jan 7. PMID: 25616902.
9: KHARKEVICH DA. K farmakologii diazolina [Pharmacology of diazoline]. Farmakol Toksikol. 1957 Nov-Dec;20(6):46-51. Russian. PMID: 13562138.
10: Verstraete E, Boelens J, De Coen K, Claeys G, Vogelaers D, Vanhaesebrouck P, Blot S. Healthcare-associated bloodstream infections in a neonatal intensive care unit over a 20-year period (1992-2011): trends in incidence, pathogens, and mortality. Infect Control Hosp Epidemiol. 2014 May;35(5):511-8. doi: 10.1086/675836. Epub 2014 Mar 17. PMID: 24709719.
